These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 34012213)

  • 1. Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study.
    Kaftan AN; Hussain MK; Algenabi AA; Naser FH; Enaya MA
    Acta Inform Med; 2021 Mar; 29(1):45-50. PubMed ID: 34012213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COVID-19 Real-Time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) Cycle Threshold Value With Surrogate Markers of Disease Severity.
    John JE; Amle DB; Takhelmayum R; Gopal N; Mishra M; Joshi P; Rathod B; Gadkari R
    Cureus; 2022 Nov; 14(11):e31034. PubMed ID: 36475201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19.
    Patel SV; Pathak JM; Parikh RJ; Pandya KJ; Kothari PB; Patel A
    Cureus; 2024 Feb; 16(2):e54840. PubMed ID: 38533136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019.
    Santotoribio JD; Nuñez-Jurado D; Lepe-Balsalobre E
    Clin Lab; 2020 Sep; 66(9):. PubMed ID: 32902237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of laboratory parameters in predicting severity of COVID-19 disease in pregnant patients.
    Sahin O; Aktoz F; Bagci H; Vurgun E
    J Obstet Gynaecol; 2022 Aug; 42(6):1917-1921. PubMed ID: 35603633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones.
    Haroun RA; Osman WH; Amin RE; Eessa AM; Saad S
    Int Immunopharmacol; 2023 Sep; 122():110626. PubMed ID: 37459785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of combined measurement of C-reactive protein, erythrocyte sedimentation rate, lactate dehydrogenase and serum ferritin in etiological diagnosis of fever of unknown origin in children].
    Xie T; Pan JH; Zhang X
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):950-5. PubMed ID: 26412177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute Lymphocytes, Ferritin, C-Reactive Protein, and Lactate Dehydrogenase Predict Early Invasive Ventilation in Patients With COVID-19.
    Payán-Pernía S; Gómez Pérez L; Remacha Sevilla ÁF; Sierra Gil J; Novelli Canales S
    Lab Med; 2021 Mar; 52(2):141-145. PubMed ID: 33336243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
    Punzalan FER; Aherrera JAM; de Paz-Silava SLM; Mondragon AV; Malundo AFG; Tan JJE; Tantengco OAG; Quebral EPB; Uy MNAR; Lintao RCV; Dela Rosa JGL; Mercado MEP; Avenilla KC; Poblete JB; Albay AB; David-Wang AS; Alejandria MM
    Front Immunol; 2023; 14():1123497. PubMed ID: 36926338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
    Sukrisman L; Sinto R
    J Int Med Res; 2021 Nov; 49(11):3000605211059939. PubMed ID: 34796762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients.
    Izhari MA
    Infect Drug Resist; 2024; 17():1653-1667. PubMed ID: 38707987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of inflammatory markers as predictor for mechanical ventilation in COVID-19 patients with stages IIIb-V chronic kidney disease?
    Shanmugavel Geetha H; Prabhu S; Sekar A; Gogtay M; Singh Y; Mishra AK; Abraham GM; Martin S
    World J Virol; 2023 Dec; 12(5):286-295. PubMed ID: 38187498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Biochemical Markers in Predicting Severe COVID-19: Experience from a Tertiary Hospital in South India.
    Shenoy MT; Mohanty PK; Suganthy K; Manavalan JK; Alexander H
    EJIFCC; 2022 Aug; 33(2):131-144. PubMed ID: 36313911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Routine Biomarkers of SARS-CoV-2 Morbidity and Mortality: Outcomes from an Emergency Section.
    Ceci FM; Fiore M; Gavaruzzi F; Angeloni A; Lucarelli M; Scagnolari C; Bonci E; Gabanella F; Di Certo MG; Barbato C; Petrella C; Greco A; Vincentiis M; Ralli M; Passananti C; Poscia R; Minni A; Ceccanti M; Tarani L; Ferraguti G
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing unnecessary routine laboratory testing for noncritically ill patients with COVID-19.
    Shin D; Krouss M; Alaiev D; Mestari N; Talledo J; Zaurova M; Chandra K; Manchego PA; Tsega S; Uppal A; Faillace RT; Moskovitz J; Ford K; Bouton M; Cho HJ
    J Hosp Med; 2022 Dec; 17(12):961-966. PubMed ID: 36330542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.